Heli Silvennoinen1, Teemu Huusko, Tytti Vuorinen, Terho Heikkinen. 1. From the *Department of Pediatrics, Turku University Hospital, Turku, Finland; †Department of Pediatrics, University of Turku, Turku, Finland; ‡Division of Microbiology and Genetics, Department of Clinical Virology, Turku University Hospital, Turku, Finland; and §Department of Virology, University of Turku, Turku, Finland.
Abstract
BACKGROUND: Few studies have directly compared the clinical impact of different types and subtypes of influenza viruses in children. METHODS: In a prospective study of respiratory infections in preenrolled cohorts of children ≤13 years of age, we compared the clinical features and the overall burden of illness between outpatient children with A/H1N1, A/H3N2 and B infections. The data were derived from structured medical records filled out by study physicians and from daily symptom diaries filled out by the parents throughout the follow-up period. RESULTS: Of 358 children included in the analyses, 203 (57%) had influenza A/H1N1, 96 (27%) had A/H3N2, and 59 (16%) had influenza B infection. Children with influenza A/H3N2 were significantly younger (median, 3.2 years) than those with A/H1N1 (median, 4.8 years) or B (median, 5.1 years) infections (P < 0.0001). When adjusted for age, children 3-6 years of age with A/H3N2 infection had a higher frequency of fever ≥39.0°C (67% vs. 38%; P = 0.002), longer duration of fever (median, 4 vs. 3 days; P = 0.02) and more antibiotic treatments (43% vs. 20%; P = 0.004) than did children with A/H1N1 infections. Overall, the clinical presentation, duration of illness, frequency of complications, children's absenteeism from day care or school and parental work absenteeism were comparable between children with A/H1N1, A/H3N2 and B infections. CONCLUSIONS: Adjusted for age, the clinical manifestations and the burden of illness are largely comparable between children with influenza A/H1N1, A/H3N2 and B infections.
BACKGROUND: Few studies have directly compared the clinical impact of different types and subtypes of influenza viruses in children. METHODS: In a prospective study of respiratory infections in preenrolled cohorts of children ≤13 years of age, we compared the clinical features and the overall burden of illness between outpatientchildren with A/H1N1, A/H3N2 and B infections. The data were derived from structured medical records filled out by study physicians and from daily symptom diaries filled out by the parents throughout the follow-up period. RESULTS: Of 358 children included in the analyses, 203 (57%) had influenza A/H1N1, 96 (27%) had A/H3N2, and 59 (16%) had influenza B infection. Children with influenza A/H3N2 were significantly younger (median, 3.2 years) than those with A/H1N1 (median, 4.8 years) or B (median, 5.1 years) infections (P < 0.0001). When adjusted for age, children 3-6 years of age with A/H3N2infection had a higher frequency of fever ≥39.0°C (67% vs. 38%; P = 0.002), longer duration of fever (median, 4 vs. 3 days; P = 0.02) and more antibiotic treatments (43% vs. 20%; P = 0.004) than did children with A/H1N1 infections. Overall, the clinical presentation, duration of illness, frequency of complications, children's absenteeism from day care or school and parental work absenteeism were comparable between children with A/H1N1, A/H3N2 and B infections. CONCLUSIONS: Adjusted for age, the clinical manifestations and the burden of illness are largely comparable between children with influenza A/H1N1, A/H3N2 and B infections.
Authors: Huong Q McLean; Siri H Peterson; Jennifer P King; Jennifer K Meece; Edward A Belongia Journal: Influenza Other Respir Viruses Date: 2017-02-15 Impact factor: 4.380
Authors: Saverio Caini; Peter Spreeuwenberg; Gabriela F Kusznierz; Juan Manuel Rudi; Rhonda Owen; Kate Pennington; Sonam Wangchuk; Sonam Gyeltshen; Walquiria Aparecida Ferreira de Almeida; Cláudio Maierovitch Pessanha Henriques; Richard Njouom; Marie-Astrid Vernet; Rodrigo A Fasce; Winston Andrade; Hongjie Yu; Luzhao Feng; Juan Yang; Zhibin Peng; Jenny Lara; Alfredo Bruno; Doménica de Mora; Celina de Lozano; Maria Zambon; Richard Pebody; Leticia Castillo; Alexey W Clara; Maria Luisa Matute; Herman Kosasih; Simona Puzelli; Caterina Rizzo; Herve A Kadjo; Coulibaly Daouda; Lyazzat Kiyanbekova; Akerke Ospanova; Joshua A Mott; Gideon O Emukule; Jean-Michel Heraud; Norosoa Harline Razanajatovo; Amal Barakat; Fatima El Falaki; Sue Q Huang; Liza Lopez; Angel Balmaseda; Brechla Moreno; Ana Paula Rodrigues; Raquel Guiomar; Li Wei Ang; Vernon Jian Ming Lee; Marietjie Venter; Cheryl Cohen; Selim Badur; Meral A Ciblak; Alla Mironenko; Olha Holubka; Joseph Bresee; Lynnette Brammer; Phuong Vu Mai Hoang; Mai Thi Quynh Le; Douglas Fleming; Clotilde El-Guerche Séblain; François Schellevis; John Paget Journal: BMC Infect Dis Date: 2018-06-08 Impact factor: 3.090
Authors: Michael Hinojosa; Samuel S Shepard; Jessie R Chung; Jennifer P King; Huong Q McLean; Brendan Flannery; Edward A Belongia; Min Z Levine Journal: J Infect Dis Date: 2021-08-02 Impact factor: 5.226